DiaMedica Therapeutics Inc. DMAC
Set alert
9.29 USD +0.04 +0.43%
At close · Nov 2
9.29 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
8.96 Day range 9.51
5.25 52-week range 10.42
- YTD
- +16.71%
- 1 year
- +31.59%
- Open
- 9.33
- Prev close
- 9.25
- Mkt cap
- 500.97M
- Vol
- 141.54K
- Avg vol
- 185.28K
- EPS
- -0.72
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.96
- High
- 9.51
- Forward P/E
- -7.26
- Beta
- 1.46
- Short ratio
- 3.88
- Inst. own
- 31.61%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 4.69
- 200-d avg
- 3.61
- 1y target
- 7.00
1m chart
Built from the cached one-day intraday bars.
Signals (56)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 3:36 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 3:36 PM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 3:36 PM | 12 hours ago |
| RSI: Overbought | Nov 2, 3:36 PM | 12 hours ago |
| RSI: Oversold | Nov 2, 3:25 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 3:22 PM | 12 hours ago |
| RSI: Overbought | Nov 2, 3:18 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 3:13 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 3:12 PM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 3:02 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 2:58 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 2:40 PM | 13 hours ago |
| RSI: Overbought | Nov 2, 2:40 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 2:37 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 2:34 PM | 13 hours ago |
| RSI: Overbought | Nov 2, 2:28 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 2:15 PM | 13 hours ago |
| RSI: Overbought | Nov 2, 2:15 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 2:09 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 2:01 PM | 13 hours ago |
Newest 20 of 56.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 7.00 -24.7% downside
Now 9.29
- Target (low)
- 6.00
- Target (mean)
- 7.00
- Target (high)
- 8.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.1725 | -0.18 – -0.16 | -0.14 | -23.2% | 0 | 0.0% | 4 |
| Next quarter | -0.20 | -0.21 – -0.19 | -0.14 | -42.9% | 0 | 0.0% | 2 |
| Current year | -0.5925 | -0.60 – -0.58 | -0.60 | +1.3% | 0 | 0.0% | 4 |
| Next year | -0.79 | -0.89 – -0.68 | -0.5925 | -33.3% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 7, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 16, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Mar 21, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Mar 21, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jun 22, 2023 | Oppenheimer | Upgrade | Perform | Outperform |
| Jul 7, 2022 | Lake Street | Maintained | — | Buy |
| Jul 7, 2022 | Craig-Hallum | Maintained | — | Buy |
| Jul 7, 2022 | Oppenheimer | Downgrade | Outperform | Perform |
| Jun 30, 2021 | Roth Capital | Maintained | — | Buy |
| Apr 8, 2021 | Oppenheimer | Initiated | — | Outperform |
| Feb 17, 2021 | Roth Capital | Initiated | — | Buy |
| Jul 8, 2020 | Maxim Group | Initiated | — | Buy |
| May 15, 2020 | Craig-Hallum | Maintained | — | Buy |